Status:
UNKNOWN
Pro-inflammatory Cytokines Profile and Mortality Rate of Critically Ill Septic Patients Following Plasmapheresis
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Severe Sepsis
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Sepsis is one of the most prevalent and fatal diseases in intensive care units .unfortunately, therapeutic approach to sepsis has remained unchanged for many years. Nowadays, the role of cytokines in ...
Detailed Description
Method 27 patients with sepsis less than 24 hours, admitted in ICU, 16- 60 years old, male and female, randomized divided two groups(P=12, S=15) study in randomized clinical trial. Inclusion criteria...
Eligibility Criteria
Inclusion
- Severe sepsis criteria which were defined by the ACCP/SCCM consensus conference
Exclusion
- Post CPR, pregnant and under 16 years old patients
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2011
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01249222
Start Date
November 1 2008
End Date
February 1 2011
Last Update
November 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tehran University of Medical sciences, Imam hospital
Tehran, Tehran Province, Iran, 1417653761